Cumberland Pharmaceuticals (CPIX) Net Equity Issued and Repurchased (2018)

Cumberland Pharmaceuticals (CPIX) posted Net Equity Issued and Repurchased of -$909.0 for Q3 2018, down 200.0% sequentially from $909.0 in Q2 2018.

Cumberland Pharmaceuticals (CPIX) Net Equity Issued and Repurchased (2018) Analysis & Trends

Cumberland Pharmaceuticals has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at -$909.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	700,000.00
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	84.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Cumberland Pharmaceuticals	114.68 Mn	110.82 Mn	-	-

Download Data